Your browser doesn't support javascript.
loading
Clarifying the categorization of anaphylaxis as an adverse event during oral immunotherapy.
Turner, Paul J; Patel, Nandinee; Rodríguez Del Río, Pablo.
Affiliation
  • Turner PJ; National Heart and Lung Institute, Imperial College London, London, United Kingdom. Electronic address: p.turner@imperial.ac.uk.
  • Patel N; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Rodríguez Del Río P; Hospital Universitario Niño Jesús, Madrid, Spain.
J Allergy Clin Immunol ; 150(1): 229-230, 2022 07.
Article in En | MEDLINE | ID: mdl-35491265
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anaphylaxis Type of study: Etiology_studies Limits: Humans Language: En Journal: J Allergy Clin Immunol Year: 2022 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anaphylaxis Type of study: Etiology_studies Limits: Humans Language: En Journal: J Allergy Clin Immunol Year: 2022 Document type: Article Country of publication: United States